Suicidality during intranasal (es)ketamine treatment: A retrospective cohort study
Journal of Affective Disorders · 2027-01 · 417 · 122647
DOI: 10.1016/j.jad.2026.122647 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2027-01. Verfasst von Yamina Ehrt-Schäfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Psychology, Univ…. Hauptthemen laut MEDLINE: Ketamine, Depressive Disorder, Treatment-Resistant, Suicidal Ideation, Suicide. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Intranasal (es)ketamine has shown efficacy in therapy of treatment-resistant depression (TRD). However, its effects on suicidality have not been fully elucidated. METHODS: We conducted a retrospective longitudinal cohort study of 80 patients affected by TRD and treated with intranasal (es)ketamine. Suicidality was assessed using item 10 of the clinician-rated Montgomery-Åsberg Depression Rating Scale (MADRS) and item 9 of the Beck-Depression-Inventory-II (BDI-II). We measured patient- and transition-level fluctuations of suicidality, tested temporal clustering using mixed-effects logistic regression, examined associations between non-suicidal depressive symptom change and suicidality worsening, and explored baseline predictors. RESULTS: Mean suicidality ratings decreased modestly. Upward and downward category transitions occurred at similar frequencies across treatment (MADRS: 57 increases and 50 decreases across 767 valid transitions, 7.4% vs. 6.5%; BDI-II: 22 increases and 23 decreases across 741 transitions, 3.0% vs. 3.1%). At least one upward transition occurred in 38.8% on MADRS and 21.3% on BDI-II. Transient elevations were more frequent than sustained elevations. Sustained elevation occurred at 15.0% on MADRS and 7.5% on BDI-II. Increases did not cluster by treatment phase. MADRS, but not BDI-II, upward transitions were associated with concurrent and lagged worsening in non-suicidal depressive symptoms. Higher baseline suicidality showed the most consistent association with later worsening across both measures. Two serious adverse events occurred, including one suicide. CONCLUSIONS: In this routine-care cohort, suicidality decreased on average, with no evidence of treatment-phase-specific worsening. Nonetheless, a minority of patients showed transient or, less often, sustained increases in suicidality, supporting necessity of continuous suicidality monitoring throughout (es)ketamine treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Psychology, University of Zurich, Zurich, Switzerland.
- Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psych…
- Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: stefano.ferrea@uni-duesseldorf.de.
Zitieren
APA
Ehrt-Schäfer, Y., Schoretsanitis, G., Seifritz, E., Olbrich, S., & Ferrea, S. (2027). Suicidality during intranasal (es)ketamine treatment: A retrospective cohort study. Journal of Affective Disorders, 417, 122647. https://doi.org/10.1016/j.jad.2026.122647
Vancouver
Ehrt-Schäfer Y, Schoretsanitis G, Seifritz E, Olbrich S, Ferrea S. Suicidality during intranasal (es)ketamine treatment: A retrospective cohort study. Journal of Affective Disorders. 2027;417:122647. doi:10.1016/j.jad.2026.122647
BibTeX
@article{EhrtSchfer2027,
author = {Ehrt-Schäfer, Yamina and Schoretsanitis, Georgios and Seifritz, Erich and Olbrich, Sebastian and Ferrea, Stefano},
title = {Suicidality during intranasal (es)ketamine treatment: A retrospective cohort study},
journal = {Journal of Affective Disorders},
year = {2027},
volume = {417},
pages = {122647},
doi = {10.1016/j.jad.2026.122647}
}
EUVIMED